Make Kidney Cancer Treatment Priority- Kidney Cancer UK
World Pharma Today Magazine | For the C-level Pharma Executives
by content
16h ago
NICE, the National Institute for Health and Care Excellence, has received a plea from the Kidney Cancer UK to bring about guidelines on the diagnosis and treatment of kidney cancer as a significant priority. Although NHS England has commissioned NICE to go through the urgent work, the recent results of a survey conducted by Kidney […] The post Make Kidney Cancer Treatment Priority- Kidney Cancer UK first appeared on World Pharma Today ..read more
Visit website
Revenue Clawback Rate Increase Warned By ABPI In The UK
World Pharma Today Magazine | For the C-level Pharma Executives
by content
16h ago
The Association of the British Pharmaceutical Industry (ABPI) has urged the government to take prompt action in response to the planned UK statutory revenue clawback rate increase for branded medications. The Department of Health and Social Care (DHSC) is now conducting a significant consultation over proposals to increase from 24.4% to 27.5% of the statutory […] The post Revenue Clawback Rate Increase Warned By ABPI In The UK first appeared on World Pharma Today ..read more
Visit website
Endometrial Cancer Survival Is An Enhanced Possibility
World Pharma Today Magazine | For the C-level Pharma Executives
by content
16h ago
A Phase III trial found that pembrolizumab plus chemotherapy enhanced survival in endometrial cancer patients. A Phase III clinical trial comparing pembrolizumab to chemotherapy (carboplatin and paclitaxel) enhanced progression-free survival (PFS) in patients with stage III-IV or recurrent endometrial cancer. As per the interim analysis of the result, the treatment went on to show a […] The post Endometrial Cancer Survival Is An Enhanced Possibility first appeared on World Pharma Today ..read more
Visit website
The ePI Deconstructed – A New Frontier in Patient Communication
World Pharma Today Magazine | For the C-level Pharma Executives
by content
16h ago
Pharma manufacturers face several challenges when it comes to labels, both in terms of design and production. As the label size tends to increase every year, adding clarity, consistency, and appeal is becoming increasingly difficult. Pharmaceutical manufacturers also face new legislative and Regulatory requirements on top of the existing challenges. The information that patients need, […] The post The ePI Deconstructed – A New Frontier in Patient Communication first appeared on World Pharma Today ..read more
Visit website
RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies
World Pharma Today Magazine | For the C-level Pharma Executives
by content
22h ago
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced a significant milestone: they have de-risked over 1000 clinical studies. With over 6,000 platform users and more than 100,000 issues detected, CluePoints is proud to have been an integral player in the adoption of Risk-Based Monitoring (RBM) and later […] The post RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies first appeared on World Pharma Today ..read more
Visit website
What are some of the key challenges pharma has faced in 2022? Will these continue into 2023?
World Pharma Today Magazine | For the C-level Pharma Executives
by content
2d ago
As 2023 takes over, there is a lot of hope that makes us cling to the pharmaceutical sector: a hope of getting novel ideas to work, a hope to embrace more technology, and a hope to fill the gap. To see what one can expect in 2023, which for many looks to be a year of turnaround […] The post What are some of the key challenges pharma has faced in 2022? Will these continue into 2023? first appeared on World Pharma Today ..read more
Visit website
Regenerative Treatment For An Impaired Kidney Restoration
World Pharma Today Magazine | For the C-level Pharma Executives
by content
2d ago
An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues in Germany, and the National Heart Centre Singapore (NHCS), suggesting that regenerative treatment to restore damaged kidney function could be a sure possibility. In a preclinical study, the researchers discovered that suppressing the harmful and scar-regulating protein interleukin-11 (IL-11) allowed […] The post Regenerative Treatment For An Impaired Kidney Restoration first appeared on World Pharma Today ..read more
Visit website
Fatty Liver Disease Gets A Novel Drug Healing Contender
World Pharma Today Magazine | For the C-level Pharma Executives
by content
2d ago
Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication of non-alcoholic fatty liver disease. There is presently no treatment for non-alcoholic fatty liver disease, which affects individuals with type 2 diabetes and can develop into other extreme liver problems. The researchers discovered an antibody that can inhibit the protein […] The post Fatty Liver Disease Gets A Novel Drug Healing Contender first appeared on World Pharma Today ..read more
Visit website
Clinical Trials Information System A Must In The EU Now
World Pharma Today Magazine | For the C-level Pharma Executives
by content
5d ago
All initial clinical trial applications across the EU have to be submitted via the Clinical Trials Information System (CTIS) starting January 31, 2023. As per the European Medicines Agency (EMA), CTIS now happens to be the single-entry point for regulators as well as sponsors of clinical trials when it comes to the submission and assessment […] The post Clinical Trials Information System A Must In The EU Now first appeared on World Pharma Today ..read more
Visit website
Mechanism For Lung Adenocarcinoma Established By Researchers
World Pharma Today Magazine | For the C-level Pharma Executives
by content
5d ago
Researchers have identified the mechanism that is responsible for the formation of cancer-associated fibroblasts, which happen to be essential for lung adenocarcinoma. Lung adenocarcinoma is the most frequent type of cancer of the lungs. It is related to cancer cells that happen to play a role in all stages of tumour formation, such as metastasis. […] The post Mechanism For Lung Adenocarcinoma Established By Researchers first appeared on World Pharma Today ..read more
Visit website

Follow World Pharma Today Magazine | For the C-level Pharma Executives on Feedspot

Continue with Google
OR